Silfurberg is a family office - single based in Reykjavik, Iceland, founded in 2002. Verified contact details, AUM data, and investment preferences on FindLPs.
Silfurberg is a private investment company located in Reykjavik, Iceland. Silfurberg has an investment background in the life science industry and venture capital investments in the fields of healthcare and biotech. Silfurberg's founders and BoD are entrepreneurial investors in the pharmaceutical industry and the founder of Invent Farma and Omega Farma. Established in 2002, it is the family office of Mr. Frithrik Steinn Kristjansson and Mr. Ingibjorg Jonsdottir who have an equal share in Silfurberg. Silfurberg is currently investing in private equity including buyouts, diversified private equity, private equity growth expansion, and venture capital fund strategies, diversified across the world.
Investment types: Buyout, Private Equity, Growth/Expansion, Venture Capital, Venture Capital - Early Stage, Venture Capital - Later Stage
Sectors & themes: Biomedical Technology & Medical Research, Healthcare Services, Pharmaceutical Research & Development Biotechnology & Life Sciences, Healthcare, Healthcare & Life Sciences
Preferred geographies: Europe, United Kingdom, United States, Global
Location: Suðurgata 22\nReykjavik, Iceland\n101\nIceland
FindLPs holds verified direct email addresses and phone numbers for decision-makers at Silfurberg. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.
Unlock Contact DetailsSearch 25,850 limited partners with verified contact details.
LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.